DNA Forensic Testing Industry Faces Challenge To Credibility

On Feb. 5, 1987, Vilma Ponce and her infant daughter were stabbed to death in their Bronx, N.Y., apartment. Police arrested a suspect, Joseph Castro, on whose wristwat they found a small bloodstain. The police took the evidence to Lifecodes Corp. in Valhalla, N.Y., where lab analysis convinced the company’s scientists that DNA retrieved from the blood on the watchface matched that of the dead woman. If true, this would have put Castro at the scene of the crime. Chances of the match bei

Written byJulia King
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

On Feb. 5, 1987, Vilma Ponce and her infant daughter were stabbed to death in their Bronx, N.Y., apartment. Police arrested a suspect, Joseph Castro, on whose wristwat they found a small bloodstain. The police took the evidence to Lifecodes Corp. in Valhalla, N.Y., where lab analysis convinced the company’s scientists that DNA retrieved from the blood on the watchface matched that of the dead woman. If true, this would have put Castro at the scene of the crime. Chances of the match being coincidental were 100 million to one, Lifecodes scientists later testified.

But late last summer, two and a half years after Castro’s arrest, a New York State Supreme Court judge, Gerald Scheindlin. ruled that those odds were not good enough to convict the suspect. Indeed, the judge ruled in a pretrial hearing, Lifecodes’ DNA test results were not even reliable enough to be used as evidence against ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies